Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma
Open Access
- 12 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (8) , ofae404
Abstract
Background: Reemergence of human herpesvirus 8 (HHV-8)–induced Kaposi sarcoma (KS) in people living with HIV (PLWH) despite antiretroviral therapy (ART) poses a clinical challenge because they already have favorable CD4 T-cell numbers and undetectable viral loads. We observed that clinical presentation in PLWH on ART resembled classic KS found in older HIV-uninfected patients and hypothesized that immunosenescence may thus play a role in occurrence of KS on ART. We compared viral and immune factors implicated in the development of KS in ART-treated PLWH (HIV KS) and HIV-uninfected classic KS patients (cKS), compared to controls without KS (HIV Control, cControls respectively). Methods: Plasma, peripheral blood mononuclear cell, and skin tissues were obtained from 11 HIV KS and 11 cKS patients and 2 groups of age-matched controls. Results: HIV KS participants were younger than cKS (aged 53 vs 75 years). HHV-8 genotypes did not differ between groups. Despite the younger age and a lower CD4/CD8 ratio, activated, exhausted, and senescent T-cell frequencies were similar between HIV KS and cKS. Anti–HHV-8 immunoglobulin G levels were higher and circulating HHV-8 DNA lower in HIV KS compared with cKS. Circulating platelet-derived growth factors AA-BB and granulocyte colony-stimulating factors were higher in HIV KS We observed similar levels of HHV-8 DNA and PD-1 expression in skin lesions from HIV KS and cKS patients. Conclusions: Altogether, early immune senescence could be involved in the development of KS in ART-treated PLWH. Higher anti–HHV-8 immunoglobulin G levels could be linked with lower circulating viral load. Such insights should help developing therapeutical strategies to prevent development and treat KS in PLWH on ART.Keywords
Funding Information
- Fonds de la Recherche Québec-Santé
- FRQS
- Canadian Institutes of Health Research
- Canadian Foundation for AIDS Research
- “Fonds de perfectionnement” of the Geneva University Hospitals
- Swiss National Science Foundation
- McGill University
This publication has 24 references indexed in Scilit:
- Methods comparison for molecular diagnosis of human herpesvirus 8 infectionsJournal of Clinical Virology, 2020
- Human Immunodeficiency Virus-Associated Exosomes Promote Kaposi’s Sarcoma-Associated Herpesvirus Infection via the Epidermal Growth Factor ReceptorJournal of Virology, 2020
- New Kaposi’s sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologiesThe Journal of Infectious Diseases, 2020
- HIV-1 Tat Interacts with a Kaposi’s Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its FunctionJournal of Virology, 2020
- Kaposi sarcomaNature Reviews Disease Primers, 2019
- Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirusProceedings of the National Academy of Sciences, 2018
- Cross-Clade Ultrasensitive PCR-Based Assays To Measure HIV Persistence in Large-Cohort StudiesJournal of Virology, 2014
- Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Ubiquitin E3 Ligases Have Stage-Specific Immune Evasion Roles during Lytic ReplicationJournal of Virology, 2014
- Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200Journal of Virology, 2012
- Comparative Evaluation of Three Serological Methods for Detection of Human Herpesvirus 8-Specific Antibodies in Canadian Allogeneic Stem Cell Transplant RecipientsJournal of Clinical Microbiology, 2004